Literature DB >> 35359901

Is There Any Mosaicism in REarranged During Transfection Variant in Hirschsprung Disease's Patients?

Kristy Iskandar1, Susan Simanjaya2, Taufik Indrawan2, Alvin Santoso Kalim2, Didik Setyo Heriyanto3.   

Abstract

Background: Hirschsprung disease (HSCR) is a heterogeneous genetic disease characterized by the absence of ganglion cells in the intestinal tract. The REarranged during Transfection (RET) is the most responsible gene for its pathogenesis. RET's somatic mosaicisms have been reported for HSCR; however, they are still under-recognized. Therefore, we determined the frequency of somatic mutation of RET rs2435357 in HSCR patients at our institution.
Methods: We performed RET rs2435357 genotyping from 73 HSCR formalin-fixed and paraffin-embedded (FFPE) rectal and 60 non-HSCR controls using the PCR-RFLP method. Subsequently, we compared those frequencies of genotypes for RET rs2435357 with our previous genotyping data from 93 HSCR blood specimens.
Results: The frequencies of genotypes for RET rs2435357 in HSCR paraffin-embedded rectal were CC 0, CT 11 (15%), and TT 62 (85%), whereas their frequencies in HSCR blood samples were CC 4 (4.3%), CT 22 (23.7%), and TT 67 (72%). Those frequencies differences almost reached a significant level (p = 0.06). Moreover, the frequency of RET rs2435357 risk allele (T) was significantly higher in HSCR patients (135/146, 92.5%) than controls (46/120, 38.3%) (p = 3.4 × 10-22), with an odds ratio of 19.74 (95% confidence interval = 9.65-40.41).
Conclusion: Our study suggests somatic mosaicism in HSCR patients. These findings further imply the complexity of the pathogenesis of HSCR. Moreover, our study confirms the RET rs2435357 as a significant genetic risk factor for HSCR patients.
Copyright © 2022 Iskandar, Simanjaya, Indrawan, Kalim, Marcellus, Heriyanto and Gunadi.

Entities:  

Keywords:  Hirschsprung disease; RET rs2435357 variant; pathogenesis; somatic mosaicism; specific tissue expression

Year:  2022        PMID: 35359901      PMCID: PMC8960445          DOI: 10.3389/fped.2022.842820

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  24 in total

1.  Population variation in total genetic risk of Hirschsprung disease from common RET, SEMA3 and NRG1 susceptibility polymorphisms.

Authors:  Ashish Kapoor; Qian Jiang; Sumantra Chatterjee; Prakash Chakraborty; Maria X Sosa; Courtney Berrios; Aravinda Chakravarti
Journal:  Hum Mol Genet       Date:  2015-02-09       Impact factor: 6.150

Review 2.  What is new about the genetic background of Hirschsprung disease?

Authors:  Berta Luzón-Toro; Leticia Villalba-Benito; Ana Torroglosa; Raquel M Fernández; Guillermo Antiñolo; Salud Borrego
Journal:  Clin Genet       Date:  2019-08-05       Impact factor: 4.438

3.  Noncoding RET variants explain the strong association with Hirschsprung disease in patients without rare coding sequence variant.

Authors:  Valtter B Virtanen; Perttu P Salo; Jia Cao; Anna Löf-Granström; Lili Milani; Andres Metspalu; Risto J Rintala; Outi Saarenpää-Heikkilä; Tiina Paunio; Tomas Wester; Agneta Nordenskjöld; Markus Perola; Mikko P Pakarinen
Journal:  Eur J Med Genet       Date:  2018-07-18       Impact factor: 2.708

Review 4.  Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model.

Authors:  Maria M Alves; Yunia Sribudiani; Rutger W W Brouwer; Jeanne Amiel; Guillermo Antiñolo; Salud Borrego; Isabella Ceccherini; Aravinda Chakravarti; Raquel M Fernández; Maria-Mercè Garcia-Barcelo; Paola Griseri; Stanislas Lyonnet; Paul K Tam; Wilfred F J van Ijcken; Bart J L Eggen; Gerard J te Meerman; Robert M W Hofstra
Journal:  Dev Biol       Date:  2013-05-23       Impact factor: 3.582

5.  Do RET somatic mutations play a role in Hirschsprung disease?

Authors:  Erwin Brosens; Katherine C MacKenzie; Maria M Alves; Robert M W Hofstra
Journal:  Genet Med       Date:  2018-11       Impact factor: 8.822

6.  RET compound inheritance in Chinese patients with Hirschsprung disease: lack of penetrance from insufficient gene dysfunction.

Authors:  Qian Jiang; Yang Wang; Yang Gao; Hui Wang; Zhen Zhang; Qi Li; Shuhua Xu; Wei Cai; Long Li
Journal:  Hum Genet       Date:  2021-01-12       Impact factor: 4.132

7.  ASSOCIATION OF RS2435357 AND RS1800858 POLYMORPHISMS IN RET PROTO-ONCOGENE WITH HIRSCHSPRUNG DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Abdolhamid Amooee; Mohamad Hosein Lookzadeh; Seyed Reza Mirjalili; Seyed Mohsen Miresmaeili; Kazem Aghili; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arq Bras Cir Dig       Date:  2019-10-21

8.  Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease.

Authors:  Sumantra Chatterjee; Ashish Kapoor; Jennifer A Akiyama; Dallas R Auer; Dongwon Lee; Stacey Gabriel; Courtney Berrios; Len A Pennacchio; Aravinda Chakravarti
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

9.  Absence of the RET+3:T allele in the MTC patients.

Authors:  Pawel Borun; Sowinski Jerzy; Katarzyna Ziemnicka; Lukasz Kubaszewski; Daniel Lipinski; Andrzej Plawski
Journal:  Hered Cancer Clin Pract       Date:  2012-10-22       Impact factor: 2.857

10.  RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis.

Authors:  Chun-mei Liang; Dong-mei Ji; Xu Yuan; Ling-ling Ren; Juan Shen; Hai-yan Zhang
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.